To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses click here.
On Thursday, March 25th at 4 p.m. ET, the American Society of Transplantation and the Infectious Diseases Society of America will host a panel discussion on the use of the COVID-19 vaccines for transplant and immunocompromised patients. The panel will include experts in transplantation and will discuss available data on vaccine safety and efficacy, use of vaccines in immunocompromised patients, and management of adverse reactions.
Presentation: COVID-19 Vaccine in Transplant & Immunocompromised populations
1. Introductions:
• Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Moderator:
• Emily Blumberg, MD
Director of the Transplant Infectious Diseases Program and the Infectious Diseases Fellowship
University of Pennsylvania
Current Past President, American Society of Transplantation
2. Featured Experts:
• Robin K. Avery, MD, FIDSA, FAST
Professor of Medicine
Division of Infectious Diseases
Johns Hopkins
• Deepali Kumar, MD, MSc, FRCP(C)
Professor of Medicine
Transplant Infectious Diseases
University Health Network, Toronto
• Lara Danziger-Isakov, MD, MPH
Director, Immunocompromised Host Infectious Disease
Professor, Department of Pediatrics
Cincinnati Children’s Hospital
• Cameron R. Wolfe, MBBS, MPH, FIDSA
Associate Professor of Medicine
Transplant Infectious Diseases
Duke University
